Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma
详细信息    查看全文
文摘
The NCCN-IPI is developed to predict survival in the rituximab era. The NCCN-IPI failed to predict survival in our cohort. The NCCN-IPI may require further evaluation before routine clinical use.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.